β-Lactam antibiotic resistance: A current structural perspective

Current Opinion in Microbiology

Volumn 8, Issue 5, 2005, Pages 525-533

  Wilke, Mark S ^a   Lovering, Andrew L ^a   Strynadka, Natalie C J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; BIAPENEM; CARBAPENEM DERIVATIVE; CEFEPIME; CELL ENZYME; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN DERIVATIVE; CHLORAMPHENICOL; CLAVULANIC ACID; GAMMA GLUTAMYLTRANSFERASE; MACROLIDE; NOVOBIOCIN; PENICILLIN G; QUINOLONE DERIVATIVE; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; BACTERIAL CELL; CELL WALL; DRUG DESIGN; DRUG TARGETING; GRAM NEGATIVE BACTERIUM; HUMAN; NONHUMAN; REVIEW;

ANTI-BACTERIAL AGENTS; BACTERIA; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; BIOLOGICAL TRANSPORT, ACTIVE; DRUG DESIGN; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PENICILLIN-BINDING PROTEINS;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 25144512582     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mib.2005.08.016     Document Type: Review

References (46)

1. G.F. Weldhagen Integrons and beta-lactamases - a novel perspective on resistance Int J Antimicrob Agents 23 2004 556 562
2. J.F. Fisher, S.O. Meroueh, and S. Mobashery Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity Chem Rev 105 2005 395 424 An excellent and comprehensive review about the mechanisms of β-lactam resistance.
3. U. Heinz, and H.W. Adolph Metallo-beta-lactamases: two binding sites for one catalytic metal ion? Cell Mol Life Sci 61 2004 2827 2839
4. G. Garau, C. Bebrone, C. Anne, M. Galleni, J.M. Frere, and O. Dideberg A metallo-beta-lactamase enzyme in action: crystal structures of the monozinc carbapenemase CphA and its complex with biapenem J Mol Biol 345 2005 785 795 This article reports the crystal structures of wild-type CphA, its N220G mutant, and a complex of N220G CphA with the carbapenem substrate biapenem. As well as providing the first structures of a class B2 metallo-β-lactamase, the authors propose a novel monozinc carbapenemase mechanism based on the details of the CphA active site in complex with substrate.
5. S. Wommer, S. Rival, U. Heinz, M. Galleni, J.M. Frere, N. Franceschini, G. Amicosante, B. Rasmussen, R. Bauer, and H.W. Adolph Substrate-activated zinc binding of metallo-beta-lactamases: physiological importance of mononuclear enzymes J Biol Chem 277 2002 24142 24147
6. S.R. Palumbi Humans as the world's greatest evolutionary force Science 293 2001 1786 1790
7. K. Poole Resistance to beta-lactam antibiotics Cell Mol Life Sci 61 2004 2200 2223
8. G.A. Jacoby, and L.S. Munoz-Price The new beta-lactamases N Engl J Med 352 2005 380 391
9. Y. Chen, B. Shoichet, and R. Bonnet Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases J Am Chem Soc 127 2005 5423 5434 The crystal structures of CTX-M-9 and/or CTX-M-14 are reported in complex with glycylboronic acid transition state analogues and with the inhibitor cefoxitin. These structures represent snapshots of CTX-M progressing through β-lactam hydrolysis, (i.e. in an acylation transition state, as an acyl-enzyme intermediate, and in a deacylation transition state). To explain the inhibitory activity of cefoxitin, steric hindrance owing to the 7α-group of the cefoxitin was implicated in blocking formation of the deacylation transition state.
10. Y. Chen, J. Delmas, J. Sirot, B. Shoichet, and R. Bonnet Atomic resolution structures of CTX-M beta-lactamases: extended spectrum activities from increased mobility and decreased stability J Mol Biol 348 2005 349 362
11. F. Sanschagrin, and R.C. Levesque A specific peptide inhibitor of the class B metallo-beta-lactamase L-1 from Stenotrophomonas maltophilia identified using phage display J Antimicrob Chemother 55 2005 252 255
12. J.G. Moloughney, J.D. Thomas, and J.H. Toney Novel IMP-1 metallo-beta-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1 FEMS Microbiol Lett 243 2005 65 71
13. O.A. Phillips, A.V. Reddy, E.L. Setti, P. Spevak, D.P. Czajkowski, H. Atwal, S. Salama, R.G. Micetich, and S.N. Maiti Synthesis and biological evaluation of penam sulfones as inhibitors of beta-lactamases Bioorg Med Chem 13 2005 2847 2858
14. J.D. Buynak, H. Chen, L. Vogeti, V.R. Gadhachanda, C.A. Buchanan, T. Palzkill, R.W. Shaw, J. Spencer, and T.R. Walsh Penicillin-derived inhibitors that simultaneously target both metallo- and serine-beta-lactamases Bioorg Med Chem Lett 14 2004 1299 1304
15. A. Bonnefoy, C. Dupuis-Hamelin, V. Steier, C. Delachaume, C. Seys, T. Stachyra, M. Fairley, M. Guitton, and M. Lampilas In vitro activity of AVE1330A, an innovative broad-spectrum non-beta-lactam beta-lactamase inhibitor J Antimicrob Chemother 54 2004 410 417
16. D. Tondi, F. Morandi, R. Bonnet, M.P. Costi, and B.K. Shoichet Structure-based optimization of a non-beta-lactam lead results in inhibitors that do not up-regulate beta-lactamase expression in cell culture J Am Chem Soc 127 2005 4632 4639
17. A.M. Venkatesan, Y. Gu, O. Dos Santos, T. Abe, A. Agarwal, Y. Yang, P.J. Petersen, W.J. Weiss, T.S. Mansour, and M. Nukaga Structure-activity relationship of 6-methylidene penems bearing tricyclic heterocycles as broad-spectrum beta-lactamase inhibitors: crystallographic structures show unexpected binding of 1,4-thiazepine intermediates J Med Chem 47 2004 6556 6568
18. H.V. Melckebeke, C. Vreuls, P. Gans, P. Filee, G. Llabres, B. Joris, and J.P. Simorre Solution structural study of BlaI: implications for the repression of genes involved in beta-lactam antibiotic resistance J Mol Biol 333 2003 711 720
19. M.K. Safo, Q. Zhao, T.P. Ko, F.N. Musayev, H. Robinson, N. Scarsdale, A.H. Wang, and G.L. Archer Crystal structures of the BlaI repressor from Staphylococcus aureus and its complex with DNA: insights into transcriptional regulation of the bla and mec operons J Bacteriol 187 2005 1833 1844 This report describes the first crystal structures of BlaI in a free form and in complex with the mec operator. Although the BlaI structures closely resemble the published structures of MecI, the authors describe an up-and-down model of repressor-binding to the mec operon (versus the side-by-side model for the bla operon) and propose that proteolytic cleavage of BlaI or MecI preferentially occurs in the DNA-bound form.
20. F. Kerff, P. Charlier, M.L. Colombo, E. Sauvage, A. Brans, J.M. Frere, B. Joris, and E. Fonze Crystal structure of the sensor domain of the BlaR penicillin receptor from Bacillus licheniformis Biochemistry 42 2003 12835 12843
21. M.S. Wilke, T.L. Hills, H.Z. Zhang, H.F. Chambers, and N.C. Strynadka Crystal structures of the Apo and penicillin-acylated forms of the BlaR1 beta-lactam sensor of Staphylococcus aureus J Biol Chem 279 2004 47278 47287
22. C. Birck, J.Y. Cha, J. Cross, C. Schulze-Briese, S.O. Meroueh, H.B. Schlegel, S. Mobashery, and J.P. Samama X-ray crystal structure of the acylated beta-lactam sensor domain of BlaR1 from Staphylococcus aureus and the mechanism of receptor activation for signal transduction J Am Chem Soc 126 2004 13945 13947
23. S. Hanique, M.L. Colombo, E. Goormaghtigh, P. Soumillion, J.M. Frere, and B. Joris Evidence of an intramolecular interaction between the two domains of the BlaR1 penicillin receptor during the signal transduction J Biol Chem 279 2004 14264 14272
24. A.E. Rosato, B.N. Kreiswirth, W.A. Craig, W. Eisner, M.W. Climo, and G.L. Archer mecA-blaZ corepressors in clinical Staphylococcus aureus isolates Antimicrob Agents Chemother 47 2003 1460 1463
25. Y. Katayama, H.Z. Zhang, D. Hong, and H.F. Chambers Jumping the barrier to beta-lactam resistance in Staphylococcus aureus J Bacteriol 185 2003 5465 5472
26. A. Zervosen, W.P. Lu, Z. Chen, R.E. White, T.P. Demuth Jr., and J.M. Frere Interactions between penicillin-binding proteins (PBPs) and two novel classes of PBP inhibitors, arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-ones Antimicrob Agents Chemother 48 2004 961 969
27. A. Llinas, N. Ahmed, M. Cordaro, A.P. Laws, J.M. Frere, M. Delmarcelle, N.R. Silvaggi, J.A. Kelly, and M.I. Page Inactivation of bacterial DD-peptidase by beta-sultams Biochemistry 44 2005 7738 7746
28. N.R. Silvaggi, H.R. Josephine, A.P. Kuzin, R. Nagarajan, R.F. Pratt, and J.A. Kelly Crystal structures of complexes between the R61 DD-peptidase and peptidoglycan-mimetic beta-lactams: a non-covalent complex with a "perfect penicillin" J Mol Biol 345 2005 521 533
29. L. Chesnel, L. Pernot, D. Lemaire, D. Champelovier, J. Croize, O. Dideberg, T. Vernet, and A. Zapun The structural modifications induced by the M339F substitution in PBP2x from Streptococcus pneumoniae further decreases the susceptibility to beta-lactams of resistant strains J Biol Chem 278 2003 44448 44456
30. L. Pernot, L. Chesnel, A. Le Gouellec, J. Croize, T. Vernet, O. Dideberg, and A. Dessen A PBP2x from a clinical isolate of Streptococcus pneumoniae exhibits an alternative mechanism for reduction of susceptibility to beta-lactam antibiotics J Biol Chem 279 2004 16463 16470 Following on from the work done on PRSP strain sp328 [31], the structure of PBP2x from strain sp5259 was obtained. In this case, the mutation of residues serves more to mimic resistance effects observed in other lactam-tolerant enzymes, including the re-arrangement of strain β3 (akin to PBP2a from S. aureus) and the introduction of negative charge near the active site (akin to PBP5fm from E. faecium). In tandem with the mutants from sp328 that act to modify the environment around the active site nucleophile, these results highlight the different techniques used to confer resistance in PBP2x.
31. A. Dessen, N. Mouz, E. Gordon, J. Hopkins, and O. Dideberg Crystal structure of PBP2x from a highly penicillin-resistant Streptococcus pneumoniae clinical isolate: a mosaic framework containing 83 mutations J Biol Chem 276 2001 45106 45112
32. D. Lim, and N.C. Strynadka Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus Nat Struct Biol 9 2002 870 876
33. E. Sauvage, F. Kerff, E. Fonze, R. Herman, B. Schoot, J.P. Marquette, Y. Taburet, D. Prevost, J. Dumas, and G. Leonard The 2.4-A crystal structure of the penicillin-resistant penicillin-binding protein PBP5fm from Enterococcus faecium in complex with benzylpenicillin Cell Mol Life Sci 59 2002 1223 1232
34. P. Macheboeuf, A.M. Di Guilmi, V. Job, T. Vernet, O. Dideberg, and A. Dessen Active site restructuring regulates ligand recognition in class A penicillin-binding proteins Proc Natl Acad Sci USA 102 2005 577 582 The first structural information obtained for a class A PBP, both in the unliganded form and when complexed with β-lactams. The structure is representative of the classical PBP fold, but also provides information on the interaction with the transglycosylase domain and the regulation of enzymatic activity by way of active site opening. This work also discusses the structural effects of mutations in the related enzyme PBP1a, which is implicated in β-lactam-resistant forms of S. pneumoniae.
35. Y. Tajima Polyoxotungstates reduce the beta-lactam resistance of methicillin-resistant Staphylococcus aureus Mini Rev Med Chem 5 2005 255 268
36. M. Oliva, O. Dideberg, and M.J. Field Understanding the acylation mechanisms of active-site serine penicillin-recognizing proteins: a molecular dynamics simulation study Proteins 53 2003 88 100
37. Y. Sanbongi, T. Ida, M. Ishikawa, Y. Osaki, H. Kataoka, T. Suzuki, K. Kondo, F. Ohsawa, and M. Yonezawa Complete sequences of six penicillin-binding protein genes from 40 Streptococcus pneumoniae clinical isolates collected in Japan Antimicrob Agents Chemother 48 2004 2244 2250
38. T.A. Leski, and A. Tomasz Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: evidence for the cooperative functioning of PBP2, PBP4, and PBP2A J Bacteriol 187 2005 1815 1824
39. K. Bush, M. Macielag, and M. Weidner-Wells Taking inventory: antibacterial agents currently at or beyond phase 1 Curr Opin Microbiol 7 2004 466 476
40. C. Fuda, D. Hesek, M. Lee, K. Morio, T. Nowak, and S. Mobashery Activation for catalysis of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus by bacterial cell wall J Am Chem Soc 127 2005 2056 2057
41. L.B. Rice, S. Bellais, L.L. Carias, R. Hutton-Thomas, R.A. Bonomo, P. Caspers, M.G. Page, and L. Gutmann Impact of specific pbp5 mutations on expression of beta-lactam resistance in Enterococcus faecium Antimicrob Agents Chemother 48 2004 3028 3032
42. V. Job, A.M. Di Guilmi, L. Martin, T. Vernet, O. Dideberg, and A. Dessen Structural studies of the transpeptidase domain of PBP1a from Streptococcus pneumoniae Acta Crystallogr D Biol Crystallogr 59 2003 1067 1069
43. K. Poole Efflux-mediated antimicrobial resistance J Antimicrob Chemother 56 2005 20 51
44. J. Eswaran, E. Koronakis, M.K. Higgins, C. Hughes, and V. Koronakis Three's company: component structures bring a closer view of tripartite drug efflux pumps Curr Opin Struct Biol 14 2004 741 747
45. E.W. Yu, G. McDermott, H.I. Zgurskaya, H. Nikaido, and D.E. Koshland Jr. Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump Science 300 2003 976 980
46. G.W. Kaatz Bacterial efflux pump inhibition Curr Opin Investig Drugs 6 2005 191 198